Delivery Order SPE2DB22D1200-SPE2DB24FN2KN

Award Date 5/9/24
Potential Completion Date 5/10/24
Potential Value $12K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of UBRELVY 100 MG TABLET UD 10S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,025.07 Firm Fixed Price contract was awarded to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc., on February 7, 2024, with a completion date of February 8, 2024. The contract is not designated as a set-aside and was awarded through full and open competition. AmerisourceBergen Drug Corp holds a significant...
This federal contract award is for the delivery of UBRELVY 100 MG TABLET UD 10S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $10,756.24 and a completion date of May 6, 2024. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
This federal contract award is for the delivery of UBRELVY 100 MG TABLET UD 10S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price and has a ceiling value of $1,159.97. The contract has an ultimate completion date of January 30, 2025. This award is part of a larger Indefinite Delivery Contract...
This federal contract award is for the delivery of UBRELVY 100 MG TABLET UD 10S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an ultimate completion date of October 3, 2023, and a ceiling value of $2,481.29. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., which is a major pharmaceutical distribution company. The contract was awarded on October 2, 2023, and is a delivery order with a firm fixed price...
This federal contract award is for the delivery of the pharmaceutical product UBRELVY 100 MG TABLET UD 10S to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. (doing business as Amerisourcebergen), which is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract has a ceiling value of $1,366.12 and is a Delivery Order under a...
This federal contract award is for the supply of UBRELVY 50 MG TABLET UD 10S to the Defense Logistics Agency (DLA). The $7,061.93 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on February 20, 2025, with a completion date of February 21, 2025. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves...
This federal contract award is for the delivery of UBRELVY 100 MG TABLET UD 10S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,134.93 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distribution company. The contract is not designated with any set-aside requirements, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp holds a...
This federal contract award is for the delivery of UBRELVY 100 MG TABLET UD 10S to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $1,146.60 and a completion date of March 24, 2025. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This federal contract award is for the delivery of UBRELVY 100 MG TABLET UD 16S pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The award, valued at $4,278.67, was made on January 30, 2025, with a completion date of January 31, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is part of a...
This federal contract award is for the delivery of UBRELVY 100 MG TABLET UD 10S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a total ceiling value of $4,152.95 and an ultimate completion date of February 18, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This is a delivery order contract with a firm fixed price pricing type. The contract is not designated with a set-aside....
  • SPE2DB22D1200
    Indefinite Delivery Contract
  • SPE2DB22D1200-SPE2DB24FN2KN
    Delivery Order

This federal contract award is for the delivery of UBRELVY 100 MG TABLET UD 10S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This is a firm fixed-price delivery order contract with a ceiling value of $11,600.51 and a period of performance through May 10, 2024.

The contract was awarded on May 9, 2024 and does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order appears to be one of many supporting the DLA's procurement of essential medical commodities for military treatment facilities and veteran healthcare programs.

Generated 5/16/25, 11:52 AM